Free Trial

Enzon Pharmaceuticals (ENZN) SEC Filings & 10K Form

Enzon Pharmaceuticals logo
$0.09 +0.01 (+6.00%)
As of 04/24/2025 03:19 PM Eastern

Recent Enzon Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/01/2025
3:37 PM
Enzon Pharmaceuticals (Filer)
Form 8-A12G/A
04/01/2025
3:30 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
3:30 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
3:05 PM
Enzon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/19/2024
4:47 PM
Enzon Pharmaceuticals (Subject)
ICAHN CARL C (Filed by)
Form SC 13D/A
08/08/2024
3:36 PM
Enzon Pharmaceuticals (Filer)
Form ARS
07/29/2024
3:40 PM
Enzon Pharmaceuticals (Filer)
Form PRE 14A
07/11/2024
4:01 PM
Enzon Pharmaceuticals (Filer)
Form 8-K/A
07/02/2024
3:30 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
3:30 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:ENZN) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners